Here's the latest updates on the IRS's guidance regarding capitalizing and amortizing research and experimental expenditures.
Here's the latest updates on the IRS's guidance regarding capitalizing and amortizing research and experimental expenditures.
Despite the recent extension for processing catch-up contributions as after-tax “Roth” contributions, additional clarification is needed for plan administrators, sponsors, and other key stakeholders to fully understand their regulatory burden. Here's what we know so far.
Property tax remains one of the largest state and local tax obligations. Find out how your business can take a proactive approach to managing property tax liabilities by checking out our article on top property tax myths.
Here's what you need to know about the provisions of the SECURE 2.0 Act that are aimed at safeguarding retirement savings for working Americans.
The IRS has stopped the processing of new ERC claims until at least December 31, 2023. Find out what this means for you.
Discover how the real estate industry is adapting by turning to private capital and small banks to manage the decline in government funding.
Many taxpayers are uncertain if they are eligible to claim the Employee Retention Credit (ERC), but with a strict statute of limitations on claiming it, taxpayers should review their eligibility as soon as possible.
Healthcare organizations may be missing opportunities to align tax planning with business strategy. Are you?
New rules require taxpayers to capitalize and amortize R&E costs incurred in taxable years beginning on or after Jan. 1, 2022. Read on to learn more.
The end of the COVID-19 Public Health Emergency, along with other impending changes to Medicare and Medicaid, will result in an increased compliance and financial burden for providers. To prepare for the coming regulatory shift, providers must understand what will change, what will stay the same and how new regulations will impact them specifically.